Contents & Figures of 206-page comprehensive market report

Table of Contents & Figures

Intro­duc­tion
A win­dow into the future of med­i­cine, enter­tain­ment and business
Exec­u­tive Summary

Chap­ter I. Scop­ing the Opportunity

  1. Defin­ing and scop­ing Per­va­sive Neurotechnology
  2. Intel­lec­tu­al Prop­er­ty (IP) enables, and helps pre­view, innovation
  3. Report method­ol­o­gy, val­ue and limitations

Chap­ter II. The State of Per­va­sive Neu­rotech­nol­o­gy Patents

  1. Size, mar­ket val­ue and trends in the US, EU and rest of the world
  2. Dis­tri­b­u­tion of fil­ings world­wide by tech­nol­o­gy cat­e­gories: EEG/ qEEG, neu­romon­i­tor­ing, neu­rocog­ni­tive train­ing, tran­scra­nial stim­u­la­tion, hybrid tech
  3. Size, mar­ket val­ue and trends of USPTO fil­ings and grants
  4. Dis­tri­b­u­tion of US fil­ings by USPTO class and subclass
  5. Analy­sis of US patents and fil­ing growth by tech­nol­o­gy category

Chap­ter III. The Patent Hold­ers: rank­ing of Top 100 assignees and detailed IP pro­files of 30 leaders

  1. Dis­tri­b­u­tion by enti­ty type and tech­nol­o­gy category
  2. Method­ol­o­gy for assess­ing IP port­fo­lio strength and rank­ing patent holders
  3. Rank­ing of 100 assignees hold­ing USPTO per­va­sive neu­rotech patents
  4. Top 30 patent hold­ers by IP Strength Index
  5. Detailed IP pro­files of the Top 30 patent holders

Chap­ter IV. Analy­sis of 50 key active Patents

  1. Method­ol­o­gy to assess patent quality
  2. 50 key active patents, cat­e­go­rized by tech­nol­o­gy class
  3. Pro­file and analy­sis of each key patent

About Sharp­Brains & the Authors

Appen­dices

  • Appen­dix A. Report method­ol­o­gy in detail
  • Appen­dix B. List of 801 hold­ers of per­va­sive neu­rotech­nol­o­gy IP
  • Appen­dix C. IP Primer and Glossary

 

List of Figures in the report

E.1. Per­va­sive Neu­rotech vs. USP­TO-wide Patents Granted

E.2. Top 30 Patent Holders

1.1. Dis­tri­b­u­tion of Active and Expired US Per­va­sive Neu­rotech Patents

2.1. Size and Mar­ket Val­ue across Geography

2.2: Growth of Per­va­sive Neu­rotech IP in the US, EU and WIPO

2.3. 1990–2014 Trends in US, EU and WIPO Patent Appli­ca­tion Filings

2.4. US Patent Appli­ca­tion Fil­ings by Tech­nol­o­gy Category

2.5. WIPO Patent Appli­ca­tion by Tech­nol­o­gy Category

2.6. EU Patent Appli­ca­tions by Tech­nol­o­gy Category

2.7. Per­va­sive Neu­rotech vs. USP­TO-wide Patents Granted

2.8. Annu­al Neu­rotech US Patent Grants and Appli­ca­tion Filings

2.9. USPTO Class and Sub­class Cov­er­age for Per­va­sive Neu­rotech IP

2.10. Top USPTO Sub­class­es for Per­va­sive Neu­rotech IP

2.11. US Per­va­sive Neu­rotech Active Patent Dis­tri­b­u­tion across Tech­nol­o­gy Categories

2.12 Annu­al Neu­rotech Patent Grants By Tech­nol­o­gy Category

2.13. Annu­al EEG/ qEEG US Patent Grants and Appli­ca­tion Filings

2.14. Annu­al Neu­romon­i­tor­ing US Patent Grants and Appli­ca­tion Filings

2.15. Annu­al Neu­rocog­ni­tive Train­ing US Patent Grants and Appli­ca­tion Filings

2.16. Annu­al Tran­scra­nial Stim­u­la­tion US Patent Grants and Appli­ca­tion Filings

2.17. Annu­al Hybrid Tech US Patent Grants and Appli­ca­tion Filings

3.1. US Active Grants by Enti­ty Type

3.2. Num­ber of Patent Hold­ers by Tech­nol­o­gy Category

3.3. List­ing of Top 100 assignees

3.4. Top 30 Patent Hold­ers by IP Strength Index

4.1. Key Active EEG Patents Summary

4.2. Key Active Neu­romon­i­tor­ing Patents Summary

4.3. Key Active Neu­rocog­ni­tive Train­ing Patents Summary

4.4. Key Active Tran­scra­nial Stim­u­la­tion Patents Summary

4.5. Key Active Hybrid Patents Summary

4.6 Indi­vid­ual Pro­file of Key Active Patents

To learn more about the report and how to order it: